Free radical oxidation of cholesterol and its precursors: Implications in cholesterol biosynthesis disorders

Free Radical Research

Volumn 49, Issue 7, 2015, Pages 835-849

  Xu, L ^a,b   Porter, N A ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

7 dehydrocholesterol; Autoxidation; Oxysterol; Peroxidation; Smith Lemli Opitz syndrome

Indexed keywords

4 HYDROXYNONENAL; 7 DEHYDROCHOLESTEROL; ALKADIENE; ALPHA TOCOPHEROL; CHOLESTEROL; FREE RADICAL; HYDROGEN; OXIDIZING AGENT; OXYSTEROL; PEROXY RADICAL; POLYUNSATURATED FATTY ACID; STEROL; UNSATURATED FATTY ACID;

ADDITION REACTION; ADDUCTION; BIOLOGICAL ACTIVITY; CHEMICAL BOND; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CYCLIZATION; ELECTROPHILICITY; ENZYME CONFORMATION; FREE RADICAL OXIDATION; HUMAN; LIPID PEROXIDATION; MOLECULAR MECHANICS; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RADICAL REACTION; REACTION ANALYSIS; REVIEW; SMITH LEMLI OPITZ SYNDROME; STEROL ANALYSIS; STRUCTURE ANALYSIS; BIOSYNTHESIS; CHEMISTRY; METABOLISM; OXIDATION REDUCTION REACTION; SMITH-LEMLI-OPITZ SYNDROME;

CHOLESTEROL; FREE RADICALS; HUMANS; OXIDATION-REDUCTION; SMITH-LEMLI-OPITZ SYNDROME; STEROLS;

EID: 84936742077     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2014.985219     Document Type: Review

References (102)

1. Shrivastava S, Paila YD, Dutta A, Chattopadhyay A. Differential effects of cholesterol and its immediate biosynthetic precursors on membrane organization. Biochemistry 2008; 47: 5668-5677.
2. Rog T, Vattulainen I, Jansen M, Ikonen E, Karttunen M. Comparison of cholesterol and its direct precursors along the biosynthetic pathway: effects of cholesterol, desmosterol and 7-dehydrocholesterol on saturated and unsaturated lipid bilayers. J Chem Phys 2008; 129: 154508.
3. Brown DA, London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 1998; 14: 111-136.
4. Korade Z, Kenworthy AK. Lipid rafts, cholesterol, and the brain. Neuropharmacology 2008; 55: 1265-1273.
5. Porter JA, Young KE, Beachy PA. Cholesterol modification of hedgehog signaling proteins in animal development. Science 1996; 274: 255-259.
6. Cooper MK, Wassif CA, Krakowiak PA, Taipale J, Gong R, Kelley RI, et al. A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis. Nat Genet 2003; 33: 508-513.
7. Jurevics H, Morell P. Cholesterol for synthesis of myelin is made locally, not imported into brain. J Neurochem 1995; 64: 895-901.
8. Brown AJ, Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999; 142: 1-28.
9. Vaya J, Schipper HM. Oxysterols, cholesterol homeostasis, and Alzheimer disease. J Neurochem 2007; 102: 1727-1737.
10. Rodriguez IR, Fliesler SJ. Photodamage generates 7-keto- and 7-hydroxycholesterol in the rat retina via a free radical-mediated mechanism. Photochem Photobiol 2009; 85: 1116-1125.
11. Rodriguez IR, Larrayoz IM. Cholesterol oxidation in the retina: Implications of 7KCh formation in chronic inflammation and age-related macular degeneration. J Lipid Res 2010; 51: 2847-2862.
12. Girao H, Mota MC, Ramalho J, Pereira P. Cholesterol oxides accumulate in human cataracts. Exp Eye Res 1998; 66: 645-652.
13. Vejux A, Samadi M, Lizard G. Contribution of cholesterol and oxysterols in the physiopathology of cataract: Implication for the development of pharmacological treatments. J Ophthalmol 2011; 2011: 471947.
14. Porter FD, Scherrer DE, Lanier MH, Langmade SJ, Molugu V, Gale SE, et al. Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med 2010; 2 :56ra81.
15. Xu L, Davis TA, Porter NA. Rate constants for peroxidation of polyunsaturated fatty acids and sterols in solution and in liposomes. J Am Chem Soc 2009; 131: 13037-13044.
16. Xu L, Porter NA. Reactivities and products of free radical oxidation of cholestadienols. J Am Chem Soc 2014; 136: 5443-5450.
17. Xu L, Korade Z, Porter NA. Oxysterols from free radical chain oxidation of 7-dehydrocholesterol: Product and mechanistic studies. J Am Chem Soc 2010; 132: 2222-2232.
18. Korade Z, Xu L, Shelton R, Porter NA. Biological activities of 7-dehydrocholesterol-derived oxysterols: implications for Smith-Lemli-Opitz syndrome. J Lipid Res 2010; 51: 3259-3269.
19. Xu L, Korade Z, Rosado DA, Liu W, Lamberson CR, Porter NA. An oxysterol biomarker for 7-dehydrocholesterol oxidation in cell/mouse models for Smith-Lemli-Opitz syndrome. J Lipid Res 2011; 52: 1222-1233.
20. Xu L, Liu W, Sheflin LG, Fliesler SJ, Porter NA. Novel oxysterols observed in tissues and fluids of AY9944-treated rats - a model for Smith-Lemli-Opitz Syndrome. J Lipid Res 2011; 52: 1810-1820.
21. Xu L, Mirnics K, Bowman AB, Liu W, Da J, Porter NA, Korade Z. DHCEO accumulation is a critical mediator of pathophysiology in a Smith-Lemli-Opitz syndrome model. Neurobiol Dis 2012; 45: 923-929.
22. Korade Z, Xu L, Mirnics K, Porter NA. Lipid biomarkers of oxidative stress in a genetic mouse model of Smith-Lemli-Opitz syndrome. J Inherit Metab Dis 2013; 36: 113-122.
23. Xu L, Korade Z, Rosado DA Jr, Mirnics K, Porter NA. Metabolism of oxysterols derived from nonenzymatic oxidation of 7-dehydrocholesterol in cells. J Lipid Res 2013; 54: 1135-1143.
24. Korade Z, Xu L, Harrison FE, Ahsen R, Hart SE, Folkes OM, et al. Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome. Biol Psychiatry 2014; 75: 215-222.
25. Smith LL. Cholesterol autoxidation 1981-1986. Chem Phys Lipids 1987; 44: 87-125.
26. Sevilla C, Becker D, Sevilla M. An electron spin resonance investigation of radical intermediates in cholesterol and related compounds: relation to solid-state autoxidation. J Phys Chem 1986; 90: 2963-2968.
27. Chisolm GM, Ma G, Irwin KC, Martin LL, Gunderson KG, Linberg LF et al. 7 beta-hydroperoxycholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc Natl Acad Sci U S A 1994; 91: 11452-11456.
28. Brown AJ, Leong SL, Dean RT, Jessup W. 7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque. J Lipid Res 1997; 38: 1730-1745.
29. Quehenberger O, Armando AM, Brown AH, Milne SB, Myers DS, Merrill AH, et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res 2010; 51: 3299-3305.
30. Smith LL, Johnson BH. Biological activities of oxysterols. Free Radic Biol Med 1989; 7: 285-332.
31. Schroepfer GJ Jr. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol Rev 2000; 80: 361-554.
32. Javitt NB. Oxysteroids: a new class of steroids with autocrine and paracrine functions. Trends Endocrinol Metab 2004; 15: 393-397.
33. Javitt NB. Oxysterols: novel biologic roles for the 21st century. Steroids 2008; 73: 149-157.
34. Porter FD, Herman GE. Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res 2011; 52: 6-34.
35. Irons M, Elias ER, Salen G, Tint GS, Batta AK. Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet 1993; 341: 1414.
36. Tint GS, Irons M, Elias ER, Batta AK, Frieden R, Chen TS, Salen G. Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 1994; 330: 107-113.
37. Tint GS, Seller M, Hughes-Benzie R, Batta AK, Shefer S, Genest D, et al. Markedly increased tissue concentrations of 7-dehydrocholesterol combined with low levels of cholesterol are characteristic of the Smith-Lemli-Opitz syndrome. J Lipid Res 1995; 36: 89-95.
38. Kelley RI, Hennekam RC. The Smith-Lemli-Opitz syndrome. J Med Genet 2000; 37: 321-335.
39. Krakowiak PA, Nwokoro NA, Wassif CA, Battaile KP, Nowaczyk MJ, Connor WE, et al. Mutation analysis and description of sixteen RSH/Smith-Lemli-Opitz syndrome patients: polymerase chain reaction-based assays to simplify genotyping. Am J Med Genet 2000; 94: 214-227.
40. Honda A, Tint GS, Salen G, Batta AK, Chen TS, Shefer S. Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes. J Lipid Res 1995; 36: 1595-1601.
41. Kandutsch AA, Russell AE. Preputial gland tumor sterols. 3. A metabolic pathway from lanosterol to cholesterol. J Biol Chem 1960; 235: 2256-2261.
42. Bloch K. Sterol molecule: structure, biosynthesis, and function. Steroids 1992; 57: 378-383.
43. Holick MF, Frommer JE, McNeill SC, Richtand NM, Henley JW, Potts JT Jr. Photometabolism of 7-dehydrocholesterol to previtamin D3 in skin. Biochem Biophys Res Commun 1977; 76: 107-114.
44. Windsor K, Genaro-Mattos TC, Kim HY, Liu W, Tallman KA, Miyamoto S, et al. Probing lipid-protein adduction with alkynyl surrogates: application to Smith-Lemli-Opitz syndrome. J Lipid Res 2013; 54: 2842-2850.
45. Bjorkhem I, Diczfalusy U. Oxysterols: friends, foes, or just fellow passengers? Arterioscler. Thromb Vasc Biol 2002; 22: 734-742.
46. Vejux A, Lizard G. Cytotoxic effects of oxysterols associated with human diseases: induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol Aspects Med 2009; 30: 153-170.
47. Brown AJ, Jessup W. Oxysterols: sources, cellular storage and metabolism, and new insights into their roles in cholesterol homeostasis. Mol Aspects Med 2009; 30: 111-122.
48. Yin H, Xu L, Porter NA. Free radical lipid peroxidation: mechanisms and analysis. Chem Rev 2011; 111: 5944-5972.
49. Iuliano L. Pathways of cholesterol oxidation via non-enzymatic mechanisms. Chem Phys Lipids 2011; 164: 457-468.
50. Howard JA, Ingold JA. Absolute rate constants for hydrocarbon autoxidation.6. Alkyl aromatic and olefinic hydrocarbons. Can J Chem 1967; 45: 793-802.
51. Trenwith AB. Dissociation of 3-methylpenta-1, 4-diene and the resonance energy of the pentadienyl radical. J Chem Soc Faraday Trans I 1982; 78: 3131-3136.
52. Berkowitz J, Ellison GB, Gutman D. Three methods to measure RH bond energies. J Phys Chem 1994; 98: 2744-2765.
53. Pratt DA, Mills JH, Porter NA. Theoretical calculations of carbon-oxygen bond dissociation enthalpies of peroxyl radicals formed in the autoxidation of lipids. J Am Chem Soc 2003; 125: 5801-5810.
54. Roschek B Jr, Tallman KA, Rector CL, Gillmore JG, Pratt DA, Punta C, Porter NA. Peroxyl radical clocks. J Org Chem 2006; 71: 3527-3532.
55. Carreira LA. Determination of the torsional potential function of 1,3-butadiene. J Chem Phys 1975; 62: 3851-3854.
56. Giese B. Formation of CC bonds by addition of free radicals to alkenes. Angew Chem Int Ed 1983; 22: 753-764.
57. Porter NA, Mills KA, Carter RL. A mechanistic study of oleate autoxidation: competing peroxyl H-atom abstraction and rearrangement. J Am Chem Soc 1994; 116: 6690-6696.
58. Tallman KA, Pratt DA, Porter NA. Kinetic products of linoleate peroxidation: Rapid beta-fragmentation of nonconjugated peroxyls. J Am Chem Soc 2001; 123: 11827-11828.
59. Tallman KA, Roschek B Jr, Porter NA. Factors influencing the autoxidation of fatty acids: effect of olefin geometry of the nonconjugated diene. J Am Chem Soc 2004; 126: 9240-9247.
60. Brash AR. Autoxidation of methyl linoleate: identification of the bis-allylic 11-hydroperoxide. Lipids 2000; 35: 947-952.
61. Beckwith ALJ, Davies AG, Davison IGE, Maccoll A, Mruzek MH. The mechanisms of the rearrangements of allylic hydroperoxides: 5-alpha-hydroperoxy-3-beta-hydroxycholest-6-ene and 7-alpha-hydroperoxy-3-beta-hydroxycholest-5-ene. J Chem Soc Perkin Trans 2 1989; 7: 815-824.
62. Porter NA, Funk M. Peroxy radical cyclization as a model for prostaglandin biosynthesis. J Org Chem 1975; 40: 3614-3615.
63. Porter NA, Funk MO, Gilmore DW, Isaac R, Nixon J. The formation of cyclic peroxides from unsaturated hydroperoxides: Models for prostaglandin biosynthesis. J Am Chem Soc 1976; 98: 6000-6005.
64. Porter NA, Lehman LS, Weber BA, Smith KJ. Unified mechanism for polyunsaturated fatty acid autoxidation. Competition of peroxy radical hydrogen atom abstraction,.beta.-scission, and cyclization. J Am Chem Soc 1981; 103: 6447-6455.
65. Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts LJ II. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A 1992; 89: 10721-10725.
66. Milne GL, Yin H, Hardy KD, Davies SS, Roberts LJ. Isoprostane generation and function. Chem Rev 2011; 111: 5973-5996.
67. Roberts LJ II, Montine TJ, Markesbery WR, Tapper AR, Hardy P, Chemtob S, et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem 1998; 273: 13605-13612.
68. Russell GA. Deuterium-isotope effects in the autoxidation of aralkyl hydrocarbons. mechanism of the interaction of PEroxy radicals. J Am Chem Soc 1957; 79: 3871-3877.
69. Howard J, Ingold K. Self-reaction of sec-butylperoxy radicals. Confirmation of the Russell mechanism. J Am Chem Soc 1968; 90: 1056-1058.
70. Dix TA, Marnett LJ. Conversion of linoleic acid hydroperoxide to hydroxy, keto, epoxyhydroxy, and trihydroxy fatty acids by hematin. J Biol Chem 1985; 260: 5351-5357.
71. Bowry VW, Stocker R. Tocopherol-mediated peroxidation. The prooxidant effect of vitamin Eon the radical-initiated oxidation of human low-density lipoprotein. J Am Chem Soc 1993; 115: 6029-6044.
72. Ingold KU, Bowry VW, Stocker R, Walling C. Autoxidation of lipids and antioxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein. Proc Natl Acad Sci U S A 1993; 90: 45-49.
73. Lamberson CR, Xu L, Muchalski H, Montenegro-Burke JR, Shmanai VV, Bekish AV, et al. Unusual kinetic isotope effects of deuterium reinforced polyunsaturated fatty acids in tocopherol-mediated free radical chain oxidations. J Am Chem Soc 2014; 136: 838-841.
74. Kulig MJ, Smith LL. Sterol metabolism. XXV. Cholesterol oxidation by singlet molecular oxygen. J Org Chem 1973; 38: 3639-3642.
75. Girotti AW. Photosensitized oxidation of cholesterol in biological systems: reaction pathways, cytotoxic effects and defense mechanisms. J Photochem Photobiol B 1992; 13: 105-118.
76. Albro PW, Corbett JT, Schroeder JL. Doubly allylic hydroperoxide formed in the reaction between sterol 5,7-dienes and singlet oxygen. Photochem Photobiol 1994; 60: 310-315.
77. Albro PW, Bilski P, Corbett JT, Schroeder JL, Chignell CF. Photochemical reactions and phototoxicity of sterols: Novel self-perpetuating mechanism for lipid photooxidation. Photochem Photobiol 1997; 66: 316-325.
78. Pulfer MK, Murphy RC. Formation of biologically active oxysterols during ozonolysis of cholesterol present in lung surfactant. J Biol Chem 2004; 279: 26331-26338.
79. Pulfer MK, Taube C, Gelfand E, Murphy RC. Ozone exposure in vivo and formation of biologically active oxysterols in the lung. J Pharmacol Exp Ther 2005; 312: 256-264.
80. Gumulka J, Smith LL. Ozonation of cholesterol. J Am Chem Soc 1983; 105: 1972-1979.
81. Jaworski K, Smith LL. Ozonization of cholesterol in nonparticipating solvents. J Org Chem 1988; 53: 545-554.
82. Wang K, Bermudez E, Pryor WA. The ozonation of cholesterol: separation and identification of 2,4-dinitrophenylhydrazine derivatization products of 3 beta-hydroxy-5-oxo-5,6-secocholestan-6-al. Steroids 1993; 58: 225-229.
83. Zhang Q, Powers ET, Nieva J, Huff ME, Dendle MA, Bieschke J, et al. Metabolite-initiated protein misfolding may trigger Alzheimer's disease. Proc Natl Acad Sci U S A 2004; 101: 4752-4757.
84. Nieva J, Song BD, Rogel JK, Kujawara D, Altobel L III, Izharrudin A, et al. Cholesterol secosterol aldehydes induce amyloidogenesis and dysfunction of wild-type tumor protein p53. Chem Biol 2011; 18: 920-927.
85. Brinkhorst J, Nara SJ, Pratt DA. Hock cleavage of cholesterol 5alpha-hydroperoxide: An ozone-free pathway to the cholesterol ozonolysis products identified in arterial plaque and brain tissue. J Am Chem Soc 2008; 130: 12224-12225.
86. Shinkyo R, Xu L, Tallman KA, Cheng Q, Porter NA, Guengerich FP. Conversion of 7-dehydrocholesterol to 7-ketocholesterol is catalyzed by human cytochrome P450 7A1 and occurs by direct oxidation without an epoxide intermediate. J Biol Chem 2011; 286: 33021-33028.
87. Xu L, Sheflin LG, Porter NA, Fliesler SJ. 7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome. Biochim Biophys Acta 2012; 1821: 877-883.
88. Liu W, Xu L, Lamberson CR, Merkens LS, Steiner RD, Elias ER, et al. Assays of plasma dehydrocholesteryl esters and oxysterols from Smith-Lemli-Opitz syndrome patients. J Lipid Res 2013; 54: 244-253.
89. Goyal S, Xiao Y, Porter NA, Xu L, Guengerich FP. Oxidation of 7-Dehydrocholesterol and Desmosterol by Human Cytochrome P450 46A1. J Lipid Res 2014; 55: 1933-1943.
90. Charman CR, Ryan A, Tyrrell RM, Pearse AD, Arlett CF, Kurwa HA, et al. Photosensitivity associated with the Smith-Lemli-Opitz syndrome. Br J Dermatol 1998; 138: 885-888.
91. Sikora D, Pettit-Kekel K, Penfield J, Merkens L, Steiner R. The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. Am J Med Genet 2006; 140A: 1511-1518.
92. Weenen H, Porter NA. Autoxidation of model membrane systems: Cooxidation of polyunsaturated lecithins with steroids, fatty acids, and alpha-tocopherol. J Am Chem Soc 1982; 104: 5216-5221.
93. De Fabiani E, Caruso D, Cavaleri M, Galli Kienle M, Galli G. Cholesta-5,7,9(11)-trien-3 beta-ol found in plasma of patients with Smith-Lemli-Opitz syndrome indicates formation of sterol hydroperoxide. J Lipid Res 1996; 37: 2280-2287.
94. Vaughan DK, Peachey NS, Richards MJ, Buchan B, Fliesler SJ. Light-induced exacerbation of retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome. Exp Eye Res 2006; 82: 496-504.
95. Richards MJ, Nagel BA, Fliesler SJ. Lipid hydroperoxide formation in the retina: correlation with retinal degeneration and light damage in a rat model of Smith-Lemli-Opitz syndrome. Exp Eye Res 2006; 82: 538-541.
96. Valencia A, Kochevar IE. Ultraviolet A induces apoptosis via reactive oxygen species in a model for Smith-Lemli-Opitz syndrome. Free Radic Biol Med 2006; 40: 641-650.
97. Valencia A, Rajadurai A, Carle AB, Kochevar IE. 7-Dehydrocholesterol enhances ultraviolet A-induced oxidative stress in keratinocytes: Roles of NADPH oxidase, mitochondria, and lipid rafts. Free Radic Biol Med 2006; 41: 1704-1718.
98. Gaoua W, Chevy F, Roux C, Wolf C. Oxidized derivatives of 7-dehydrocholesterol induce growth retardation in cultured rat embryos: a model for antenatal growth retardation in the Smith-Lemli-Opitz syndrome. J Lipid Res 1999; 40: 456-463.
99. Schneider C, Tallman KA, Porter NA, Brash AR. Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of non-enzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. J Biol Chem 2001; 276: 20831-20838.
100. Schopfer FJ, Cipollina C, Freeman BA. Formation and signaling actions of electrophilic lipids. Chem Rev 2011; 111: 5997-6021.
101. Kelley RI. Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. Clin Chim Acta 1995; 236: 45-58.
102. Haas D, Garbade SF, Vohwinkel C, Muschol N, Trefz FK, Penzien JM, et al. Effects of cholesterol and simvastatin treatment in patients with Smith-Lemli-Opitz syndrome (SLOS). J Inherit Metab Dis 2007; 30: 375-387.